[Federal Register Volume 65, Number 83 (Friday, April 28, 2000)]
[Notices]
[Pages 24985-24986]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-10667]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 24, 2000, Eli-Elsohly 
Laboratories, Inc., 5 Industrial Park Drive, Oxford, Mississippi 38655, 
made application by renewal to the Drug Enforcement Administration 
(DEA) for registration as a bulk manufacturer of the basic classes of 
controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Dihydromorphine (9145).....................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Benzoylecqonine(9180)......................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The firm plans to bulk manufacture non-deuterated controlled 
substances for use as analytical standards and deuterated controlled 
substances for ause as internal standards.
    Any other such applicant and any person who is persently registered 
with DEA to manufacturer such substance may file comments or objections 
to the issance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to

[[Page 24986]]

the Deputy Assistance Administrator, office of Diversion Control, Drug 
Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than June 27, 2000.

    Dated: April 18, 2000.
John H. King,
Deputy Assistant Administrator, Office of Division Control, Drug 
Enforcement Administration.
[FR Doc. 00-10667 Filed 4-27-00; 8:45 am]
BILLING CODE 4410-09-M